HIV-1/Mycobacterium tuberculosis Coinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?

CR Diedrich, JAL Flynn - Infection and immunity, 2011 - Am Soc Microbiol
Human immunodeficiency virus type 1 (HIV) and Mycobacterium tuberculosis have become
intertwined over the past few decades in a “syndemic” that exacerbates the morbidity and …

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

SD Lawn, LG Bekker, RF Miller - The Lancet infectious diseases, 2005 - thelancet.com
Immune reconstitution disease (IRD) in HIV-infected patients is an adverse consequence of
the restoration of pathogen-specific immune responses during the initial months of highly …

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society–USA panel

SM Hammer, MS Saag, M Schechter, JSG Montaner… - Jama, 2006 - jamanetwork.com
ContextGuidelines for antiretroviral therapy are important for clinicians worldwide given the
complexity of the field and the varied clinical situations in which these agents are used. The …

Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection

RAM Breen, CJ Smith, H Bettinson, S Dart, B Bannister… - Thorax, 2004 - thorax.bmj.com
Background: It has been suggested that deterioration of tuberculosis (TB) during appropriate
treatment, termed a paradoxical reaction (PR), is more common and severe in HIV positive …

Diagnostic and management challenges for childhood tuberculosis in the era of HIV

BJ Marais, SM Graham, MF Cotton… - The Journal of …, 2007 - academic.oup.com
The diagnosis and management of childhood tuberculosis (TB) pose substantial challenges
in the era of the human immunodeficiency virus (HIV) epidemic. The highest TB incidences …

Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

Antiretroviral Therapy Cohort … - Clinical Infectious …, 2005 - academic.oup.com
Background. We obtained estimates of the incidence of tuberculosis (TB) among patients
receiving HAART and identified determinants of the incidence. Methods. We analyzed the …

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources

SD Lawn, R Wood, KM De Cock, K Kranzer… - The Lancet infectious …, 2010 - thelancet.com
Antiretroviral therapy and isoniazid preventive therapy (IPT) are both effective interventions
to prevent HIV-associated tuberculosis, but work via different mechanisms. We propose that …

Opportunities and challenges for HIV care in overlapping HIV and TB epidemics

DV Havlir, H Getahun, I Sanne, P Nunn - Jama, 2008 - jamanetwork.com
Tuberculosis (TB) and the emerging multidrug-resistant TB epidemic represent major
challenges to human immunodeficiency virus (HIV) care and treatment programs in resource …

Improved diagnostic evaluation of suspected tuberculosis

DPS Dosanjh, TSC Hinks, JA Innes… - Annals of internal …, 2008 - acpjournals.org
Background: The role of new T-cell–based blood tests for tuberculosis in the diagnosis of
active tuberculosis is unclear. Objective: To compare the performance of 2 interferon-γ …

How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control

SD Lawn, LG Bekker, R Wood - Aids, 2005 - journals.lww.com
Use of highly active antiretroviral treatment (HAART) has had a major impact on HIV-
associated morbidity and mortality in industrialized countries. Access to HAART is now …